Table 2: Markers of coagulation activation and systemic inflammation of Type 2 diabetic patients in ESUTH based on gender.
Parameters |
Male (test) |
Female (test) |
Male (control) |
Female (control) |
P-value |
MPV |
12.65 ± 0.089 |
11.98 ± 0.65 |
7.67 ± 1.22 |
7.91 ± 1.22 |
0.001 |
PDW |
14.12 ± 1.52 |
14.38 ± 0.99 |
9.33 ± 1.0 |
927 ± 0.91 |
0.012 |
PCT |
0.27 ± 0.37 |
0.25 ± 0.30 |
0.16 ± 0.05 |
0.16 ± 0.03 |
0.043 |
NLR |
2.31 ± 0.77 |
3.47 ± 4.14 |
1.64 ± 0.58 |
1.65 ± 0.67 |
0.186* |
PLR |
82.81 ± 4.60 |
84.29 ± 3.71 |
94.7 ± 5.45 |
106.65 ± 6.09 |
0.016 |
MLR |
0.165 ± 0.165 |
0.381 ± 091 |
0.381 ± 0.91 |
0.365 ± 0.92 |
0.001 |
Key: MPV: Mean Platelet Volume; PDW: Platelet Distribution Width; PCT: Plateletcrit; NLR: Neutrophil Lymphocyte Ratio; PLR: Platelet Lymphocyte Ratio; MLR: Monocyte Lymphocyte Ratio